首页>
外国专利>
Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma
Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma
展开▼
机译:黑色素瘤抗癌治疗耐药性的治疗,诊断和评估
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to overcoming anti-cancer therapy resistance in melanoma by regulation of the expression of tyrosinase related protein 2 (TYRP2). Treatment of melanoma with anti-cancer therapy may be negatively impacted by anti-cancer resistance of melanoma cells. Altering expression of TYRP2 in melanoma cells can enhance efficacy of anti-cancer therapies, such as chemotherapy and radiotherapy. Methods for treatment of melanoma are disclosed, as well as methods for diagnosis of anti-cancer therapy resistance, and methods for evaluating candidate anti-cancer therapies for melanoma. Down-regulation of TYRP2 expression or activity can be accomplished using a genetic therapy such as antisense therapy, or by using small molecules which regulate TYRP2.
展开▼